Figure 3.
St3gal1-deficient MKs differentiate and mature normally. (A) Percentage of hematopoietic progenitors, defined as lineage negative, cKit+, and Sca-1– cells (LSK) in the BM (n = 5-6). (B) Percentage of MK progenitors MkP (Lineage–, cKit+, Sca-1–, CD150+, and CD41+ cells) and bipotent precursors, PreMegE (Lineage–, cKit+, Sca-1–, CD16/32+, CD105+, CD150– cells) in the BM (n = 5-6). (C) Plasma TPO levels determined by enzyme-linked immunosorbent assay. (D) Flow cytometric quantification of BM MK ploidy in control (blue) and ST3Gal1MK−/− (red) mice (n = 4-6). (E) Transmission electron microscopy images of MKs flushed from control and St3gal1MK−/− BMs. Scale bars, 1 μm. **P < .01.

St3gal1-deficient MKs differentiate and mature normally. (A) Percentage of hematopoietic progenitors, defined as lineage negative, cKit+, and Sca-1 cells (LSK) in the BM (n = 5-6). (B) Percentage of MK progenitors MkP (Lineage, cKit+, Sca-1, CD150+, and CD41+ cells) and bipotent precursors, PreMegE (Lineage, cKit+, Sca-1, CD16/32+, CD105+, CD150 cells) in the BM (n = 5-6). (C) Plasma TPO levels determined by enzyme-linked immunosorbent assay. (D) Flow cytometric quantification of BM MK ploidy in control (blue) and ST3Gal1MK−/− (red) mice (n = 4-6). (E) Transmission electron microscopy images of MKs flushed from control and St3gal1MK−/− BMs. Scale bars, 1 μm. **P < .01.

Close Modal

or Create an Account

Close Modal
Close Modal